A Daily Pill Cut a Stubborn Inherited Heart Risk Factor by 86 Percent in a Large Trial
The experimental drug oxavaprim lowered lipoprotein(a), a cholesterol-like particle that no approved medicine can touch, in a 9,800-patient study. Whether that prevents heart attacks will take two more years to know.

